How can you mend a broken heart? Medical device giants head to the High Court
Abbott Laboratories (market cap: €142 billion) has been battling Edwards Lifesciences (market cap: €42 billion) in US and UK courts over the Pascal, Edwards' device for fixing leaky heart valves. Now the fight is coming to Ireland.
On a war footing: How the biggest parties want to tackle the housing crisis
Based on interviews with the four major party spokespeople and independent policy experts, Sean Keyes unpacks the parties' housing strategies. He shows how the parties think about the problem, why that matters, and why Ireland has a thirty year job on its hands.
Shares in Keywords Studios are up 10x in six years. Is there anything left for investors?
In 1999, a couple based in Dublin realised they could grow their small translation business by buying up their partners from around Europe. 62 acquisitions later, the business they started is worth €1.1 billion and is a giant in the computer games industry. How big can it get?
Stolid Pearse Doherty’s radical plan: a much bigger, much more expensive state
To grow its vote share in middle Ireland, Sinn Féin needs to project solidity and competence. Pearse Doherty aims to fit the bill. In his pre-election interview, he outlines, and defends, the party's radical, ambitious, and expensive manifesto.
Access denied: The strange psychology and bad economics of open-ended property funds
What the two gated Irish property funds offer is too good to be true: the returns of a risky asset with the security of cash. They don't make a lot of sense, either for individual investors or the system as a whole.
Aviva has stopped withdrawals from two property funds. Why are investors pulling out?
Investors have been pulling out of Irish property funds. You can’t blame them. They looked at the public markets’ valuation of Irish property, and looked at their funds’ valuation of it, and decided they believed the markets.